What new vaccines are being developed?
There are more than 250 vaccines currently in various phases of development. These are intended to target a wide range of infectious diseases, cancers, allergies and diseases such as Alzheimer's. While not all of these potential vaccines will make it through the extensive testing and clinical trials successfully, those that do will bring further improvements to the health and life expectancy of people around the world.
What new vaccines are being developed for infectious diseases?
The majority of vaccines in development are aimed at providing protection against infectious diseases. These include several vaccines against human immunodeficiency virus (HIV), serious mosquito-borne diseases, such as Zika virus, and vaccines against regionally limited outbreaks such as Ebola and Lassa fever.
Advanced trials are underway for a vaccine against norovirus, which is also known as the winter vomiting bug. There are trials also underway for vaccines to prevent other stomach bugs caused by certain strains of Escherichia coli (E. coli) and Shigella.
Global efforts are underway to develop vaccines against Group A Streptococcus and Group B Streptococcus infections. Group A Streptococcus is a common cause of sore throat but can also cause severe infections which kill around 500,000 people globally each year. Group B Streptococcus causes 57,000 still births and 19,000 infant deaths globally each year.
Preventing infectious diseases with vaccines could also help tackle the growing threat posed by antimicrobial resistance, where microbes are developing the ability to resist the drugs developed to treat them, making it increasingly difficult to treat the diseases they cause.
Some diseases are particularly complicated, which makes it harder to train our immune systems against them. This can mean vaccines against these diseases are less good at preventing disease. For example, malaria is caused by a parasite spread by mosquitoes and has proved very difficult to develop a vaccine against. A vaccine against the disease was recently approved which lowers the risk of developing the disease by about 50%, which whilst not perfect, considering that there are millions of cases of malaria each year will mean large numbers of people can still benefit from protection.
Are new cancer vaccines being developed?
There are two approaches to using vaccines against cancer – preventive vaccines and therapeutic vaccines. Preventive cancer vaccines train your immune system to recognise viruses that can later cause cancer. Therapeutic vaccines train your immune system to recognise and destroy cancerous cells.
An example of preventive vaccines are those being developed against the Epstein-Barr virus, aimed at preventing certain types of lymphoma and cancers of the nose and upper throat (and might also potentially prevent multiple sclerosis). Among the many therapeutic cancer vaccines being developed are those targeting certain types of lung cancer, breast cancer, pancreatic cancer, colorectal cancer, prostate cancer, ovarian cancer and melanoma.
mRNA vaccine technology is also creating the possibility of highly tailored vaccines that could help the immune system to better identify and destroy cancer cells.
Is there a vaccine for Alzheimer's disease?
Several vaccines against Alzheimer's disease are undergoing clinical trials. Some of these are targeting the tangles of proteins that are common features in the neurons of patients with Alzheimer's. Others attempt to dial down inflammation that can damage patients' brain cells. The shingles vaccine against the chickenpox virus (varicella-zoster virus), has also been shown to potentially provide a degree of protection against Alzheimer’s Disease but further research is needed to confirm this observation.